Symbiotec Pharmalab Limited (NSE: SYMBIOTEC), ISIN INE899I01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYMBIOTEC last traded at ₹1092.80 (-0.45%), with a 52-week range of ₹933.80 to ₹1173.80 (as of 2 Sep 2026).
Shareholding as of Jun 2026: promoters 33.28%, FIIs 21.08%, DIIs 27.52%, mutual funds 5.54%.
Data sourced from NSE and BSE filings. Educational — not investment advice.